AMLX holders · CITADEL ADVISORS LLC 13F · AMLX stock
CITADEL ADVISORS LLC Amylyx Pharmaceuticals Inc (AMLX) 13F holding
CITADEL ADVISORS LLC reported 272,211 AMLX shares valued at $3.78B as of 2026-03-31 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 272,211 | $3.78B | COM |
| 2026-03-31 | 139,321 | $1.94B | COM |
| 2026-03-31 | 45,300 | $629.7M | Call |
| 2026-03-31 | 12,800 | $177.9M | Put |
| 2025-12-31 | 335,391 | $4.05B | COM |
| 2025-12-31 | 111,900 | $1.35B | Call |
| 2025-12-31 | 9,577 | $115.7M | COM |
| 2025-09-30 | 180,924 | $2.46B | COM |
| 2025-09-30 | 98,100 | $1.33B | Call |
| 2025-09-30 | 53,749 | $730.4M | COM |
| 2025-09-30 | 39,000 | $530.0M | Put |
| 2025-06-30 | 1,242,927 | $7.97B | COM |
| 2025-06-30 | 44,600 | $285.9M | Call |
Not investment advice. Cached 13F row, not EDGAR XML.